Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis

NEXT STORY
Worldwide Clinical Trials and Science 37® Partner to Advance Agile Clinical Trials™ and Accelerate Study Timelines
PREV STORY
Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AIM ImmunoTech Announces IRB Approval to Enroll COVID-19 ‘Long Haulers’ in the AMP-511 ME/CFS Clinical Trial of Ampligen

author_avatar
NASDAQ Market News

NEOVACS ANNOUNCES THE RESULTS OF ITS PHASE IIB STUDY FOR IFNalpha KINOID IN THE TREATMENT OF LUPUS

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE RESULTS OF ITS ...

author_avatar
NASDAQ Market News

Global Robotic Surgery Market 2020-2024: Adoption of Micro- and Nano- Robots in Urology Surgical Procedures, Focus on the Development of Low-Cost Robotic Surgical Systems

author_avatar
NASDAQ Market News